Back
Accuray, Inc. 10K Form
Sell
22
ARAY
Accuray, Inc.
Last Price:
$0.99
Seasonality Move:
16.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | ARAY/Accuray, Inc. Quarterly |
| 2024-02-07 | 10Q | ARAY/Accuray, Inc. Quarterly |
| 2023-11-07 | 10Q | ARAY/Accuray, Inc. Quarterly |
| 2023-09-07 | 10K | ARAY/Accuray, Inc. Annual |
| 2023-05-08 | 10Q | ARAY/Accuray, Inc. Quarterly |
| 2023-02-02 | 10Q | ARAY/Accuray, Inc. Quarterly |
Receive ARAY News And Ratings
See the #1 stock for the next 7 days that we like better than ARAY
ARAY Financial Statistics
Sales & Book Value
| Annual Sales: | $458.5M |
|---|---|
| Cash Flow: | $8.4M |
| Price / Cash Flow: | 9.64 |
| Annual Sales: | $0.55 |
| Price / Book: | 1.81 |
Profitability
| EPS (TTM): | -0.16010 |
|---|---|
| Net Income (TTM): | $-19.3M |
| Gross Margin: | $147M |
| Return on Equity: | -33.8% |
| Return on Assets: | -4.09% |
Accuray, Inc. Earnings Forecast
Key Accuray, Inc. Financial Ratios
-
The Gross Profit Margin over the past 23 years for ARAY is 32.05%.
-
The Selling, General & Administrative Expenses for ARAY have been equal to 19.89% of Gross Profit Margin.
-
The Research & Development expenses have been 10.46% of Revenue.
-
The Net Earning history of ARAY is -0.35% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 11 years.
Accuray, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | ARAY |
| CUSIP: | 004397 |
| Website: | accuray.com |
Debt
| Debt-to-Equity Ratio: | 2.9 |
|---|---|
| Current Ratio: | 1.55 |
| Quick Ratio: | 0.61 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 29.5 |
ARAY Technical Analysis vs Fundamental Analysis
Sell
22
Accuray, Inc. (ARAY)
is a Sell
Is Accuray, Inc. a Buy or a Sell?
-
Accuray, Inc. stock is rated a SellThe current Accuray, Inc. [ARAY] share price is $0.99. The Score for ARAY is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.